Dominik Glinz1, Richard F Hurrell1, Aurélie A Righetti1, Christophe Zeder1, Lukas G Adiossan1, Harold Tjalsma1, Jürg Utzinger1, Michael B Zimmermann1, Eliézer K N'Goran1, Rita Wegmüller1. 1. From the Laboratory of Human Nutrition, Institute of Food, Nutrition, and Health, Eidgenössische Technische Hochschule Zurich, Zurich, Switzerland (DG, RFH, CZ, MBZ, and RW); the Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, and University of Basel, Basel, Switzerland (AAR and JU); Hôpital Général de Taabo, Taabo Cité, Côte d'Ivoire (LGA); the Department of Laboratory Medicine (Hepcidinanalysis.com), Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands (HT); and Unité de Formation et de Recherche Biosciences, Université Félix Houphouët-Boigny, and Centre Suisse de Recherches Scientifiques en Côte d'Ivoire, Abidjan, Côte d'Ivoire (EKN).
Abstract
BACKGROUND: In sub-Saharan Africa, parasitic diseases and low bioavailable iron intake are major causes of anemia. Anemia results from inflammation, preventing iron recycling and decreasing dietary iron absorption. Hookworm, Plasmodium, and Schistosoma infections contribute to anemia, but their influence on dietary iron absorption and recycling is unknown. OBJECTIVE: The objective was to measure inflammation biomarkers, hepcidin, iron absorption, and utilization pre- and posttreatment in children with afebrile malaria, hookworm, and Schistosoma haematobium infection. DESIGN: Ivorian children aged 11-17 y with afebrile Plasmodium falciparum (n = 17), hookworm (n = 16), or S. haematobium infection (n = 8) consumed a syrup containing 3 mg ⁵⁷Fe as ferrous sulfate and received an intravenous infusion of 50 μg ⁵⁸Fe as ferrous citrate. Children were treated for their respective infection, and the iron studies were repeated 4 wk later. Iron and inflammation biomarkers and hepcidin were measured. RESULTS: Geometric mean iron absorptions in the afebrile malaria and hookworm groups were 12.9% and 32.2% (P < 0.001) before treatment and 23.6% and 30.0% (P = 0.113) after treatment, respectively. Treatment of afebrile malaria reduced inflammation (P < 0.001) and serum hepcidin (P = 0.004) and improved iron absorption (P = 0.003). Treatment of hookworm infection neither affected inflammation biomarkers nor altered iron absorption. Similarly, there was a lack of treatment effects in the S. haematobium-infected group; however, the small sample size limits conclusions. Geometric mean iron utilization ranged between 79.1% and 88.0% in the afebrile malaria and hookworm groups with no significant differences pre- and posttreatment. CONCLUSIONS: In school-age children, hookworm infection does not produce inflammation or increase serum hepcidin, and it does not influence iron absorption or utilization. In contrast, afebrile malaria causes inflammation, increases hepcidin, and reduces iron absorption but not utilization. These findings provide insights into the iron metabolism and the etiology of anemia in parasitic infections.
BACKGROUND: In sub-Saharan Africa, parasitic diseases and low bioavailable iron intake are major causes of anemia. Anemia results from inflammation, preventing iron recycling and decreasing dietary iron absorption. Hookworm, Plasmodium, and Schistosoma infections contribute to anemia, but their influence on dietary iron absorption and recycling is unknown. OBJECTIVE: The objective was to measure inflammation biomarkers, hepcidin, iron absorption, and utilization pre- and posttreatment in children with afebrile malaria, hookworm, and Schistosoma haematobium infection. DESIGN: Ivorian children aged 11-17 y with afebrile Plasmodium falciparum (n = 17), hookworm (n = 16), or S. haematobium infection (n = 8) consumed a syrup containing 3 mg ⁵⁷Fe as ferrous sulfate and received an intravenous infusion of 50 μg ⁵⁸Fe as ferrous citrate. Children were treated for their respective infection, and the iron studies were repeated 4 wk later. Iron and inflammation biomarkers and hepcidin were measured. RESULTS: Geometric mean iron absorptions in the afebrile malaria and hookworm groups were 12.9% and 32.2% (P < 0.001) before treatment and 23.6% and 30.0% (P = 0.113) after treatment, respectively. Treatment of afebrile malaria reduced inflammation (P < 0.001) and serum hepcidin (P = 0.004) and improved iron absorption (P = 0.003). Treatment of hookworm infection neither affected inflammation biomarkers nor altered iron absorption. Similarly, there was a lack of treatment effects in the S. haematobium-infected group; however, the small sample size limits conclusions. Geometric mean iron utilization ranged between 79.1% and 88.0% in the afebrile malaria and hookworm groups with no significant differences pre- and posttreatment. CONCLUSIONS: In school-age children, hookworm infection does not produce inflammation or increase serum hepcidin, and it does not influence iron absorption or utilization. In contrast, afebrile malaria causes inflammation, increases hepcidin, and reduces iron absorption but not utilization. These findings provide insights into the iron metabolism and the etiology of anemia in parasitic infections.
Authors: Sarah E Cusick; Robert O Opoka; Steven A Abrams; Chandy C John; Michael K Georgieff; Ezekiel Mupere Journal: J Nutr Date: 2016-06-29 Impact factor: 4.798
Authors: Sean Lynch; Christine M Pfeiffer; Michael K Georgieff; Gary Brittenham; Susan Fairweather-Tait; Richard F Hurrell; Harry J McArdle; Daniel J Raiten Journal: J Nutr Date: 2018-06-01 Impact factor: 4.798
Authors: Ana M Puga; María de Lourdes Samaniego-Vaesken; Ana Montero-Bravo; Mar Ruperto; Teresa Partearroyo; Gregorio Varela-Moreiras Journal: Nutrients Date: 2022-05-04 Impact factor: 6.706
Authors: Khov Kuong; Marion Fiorentino; Marlene Perignon; Chhoun Chamnan; Jacques Berger; Muth Sinuon; Vann Molyden; Kurt Burja; Megan Parker; Sou Chheng Ly; Henrik Friis; Nanna Roos; Frank T Wieringa Journal: Am J Trop Med Hyg Date: 2016-08-29 Impact factor: 2.345
Authors: Alicia Chang Cojulun; Amaya L Bustinduy; Laura J Sutherland; Peter L Mungai; Francis Mutuku; Eric Muchiri; Uriel Kitron; Charles H King Journal: Am J Trop Med Hyg Date: 2015-08-31 Impact factor: 2.345
Authors: Dominik Glinz; Richard F Hurrell; Mamadou Ouattara; Michael B Zimmermann; Gary M Brittenham; Lukas G Adiossan; Aurélie A Righetti; Burkhardt Seifert; Victorine G Diakité; Jürg Utzinger; Eliézer K N'Goran; Rita Wegmüller Journal: Malar J Date: 2015-09-17 Impact factor: 2.979
Authors: Sarah H Atkinson; Sophie M Uyoga; Andrew E Armitage; Shivani Khandwala; Cleopatra K Mugyenyi; Philip Bejon; Kevin Marsh; James G Beeson; Andrew M Prentice; Hal Drakesmith; Thomas N Williams Journal: EBioMedicine Date: 2015-08-08 Impact factor: 8.143